The clinical-stage biotech Kodiak Sciences (KOD) jumped ~15% in the morning hours Monday after the company said its BEACON Phase 3 study for lead asset tedromer met the primary endpoint...
Related Keywords
Arizona , United States , Mark Barakat , Kodiak Sciences , Retinal Research Institute , Retinal Consultants ,
comparemela.com © 2020. All Rights Reserved.